{
    "008.45:  Clostridioides difficile infection": "ChatCompletionMessage(content='- Discontinuation of antibiotics\\n- Metronidazole\\n- Vancomycin\\n- Fidaxomicin\\n- Fecal microbiota transplantation\\n- Probiotics\\n- Handwashing campaigns in hospitals\\n- Proper antibiotic prescribing\\n- Oral rehydration therapy\\n- Cholestyramine (in conjunction with other treatments)\\n- Intravenous immunoglobulin (as a last resort in immunosuppressed individuals)\\n- Monoclonal antibodies (e.g., bezlotoxumab) to prevent recurrence\\n- Surgery (for severe cases, such as colectomy)', role='assistant', function_call=None, tool_calls=None)",
    "070.54:  Liver support system": "ChatCompletionMessage(content='## Treatments for Liver Support System:\\n\\n- **Bioartificial liver devices:**\\n  - HepatAssist 2000 (uses porcine hepatocytes)\\n  - ELAD system (employs human hepatoblastoma C3A cell lines)\\n  - Bioartificial Liver Support (BLSS)\\n  - Radial Flow Bioreactor (RFB)\\n  - Hollow fiber systems\\n  - Cryogel-Based Systems\\n\\n- **Liver Transplantation (LTx)**\\n  - Considered the only effective treatment for acute liver failure (ALF) and certain cases of acute-on-chronic liver failure (ACLF)\\n\\n- **Liver dialysis**\\n  - Albumin dialysis: Single Pass Albumin Dialysis (SPAD)\\n  - Molecular Adsorbent Recirculating System (MARS)\\n  - Prometheus system (Fractionated Plasma Separation and Adsorption - FPSA)\\n  - Dialive system\\n\\n- **Specific treatments referenced**\\n  - Activation of charcoal as part of detoxification\\n  - Anticoagulation with heparin during extracorporeal treatment\\n\\n- **FDA Cleared Uses**\\n  - MARS therapy for drug overdose and poisoning\\n  - MARS therapy for hepatic encephalopathy due to decompensation of chronic liver disease\\n\\nPlease note that most treatments and devices mentioned are still in trial or experimental phases, and some, like liver transplantation and dialysis, have specific indications and require a multidisciplinary clinical team for management.', role='assistant', function_call=None, tool_calls=None)",
    "238.4:  Polycythemia vera": "ChatCompletionMessage(content='- Phlebotomy\\n- Oral chemotherapy (e.g., hydroxyurea)\\n- Interferon therapy\\n  - Long-acting interferon formulations (e.g., ropeginterferon alfa-2b)\\n- Janus kinase 2 (JAK2) inhibitor (e.g., ruxolitinib)\\n- Aspirin (for symptom management of erythromelalgia)', role='assistant', function_call=None, tool_calls=None)",
    "238.71:  Essential thrombocythemia": "ChatCompletionMessage(content='- Low-dose aspirin\\n- Hydroxycarbamide (hydroxyurea)\\n- Interferon-\u03b1\\n- Anagrelide\\n- Plateletpheresis (in symptomatic ET and extremely high platelet counts)\\n- Low molecular weight heparin (e.g., enoxaparin) during pregnancy', role='assistant', function_call=None, tool_calls=None)",
    "261:  Marasmus": "ChatCompletionMessage(content='- Treat infections with antibiotics or other medications\\n- Treat dehydration\\n- Treat circulation disorders\\n- Start feeding with dried skim milk mixed with boiled water\\n- Refeed slowly to avoid refeeding syndrome\\n- Progress to a more balanced diet to meet their nutritional needs once recovery begins', role='assistant', function_call=None, tool_calls=None)",
    "276.0:  Adipsia": "ChatCompletionMessage(content='- Training to learn when to drink water\\n- Scheduled water intake regimen\\n- Surgical removal of growths in cases where adipsia is caused by tumors affecting thirst centers\\n- Use of desmopressin acetate (DDAVP) in diabetes insipidus patients to promote reabsorption of water in the kidneys\\n- Electroconvulsive therapy for psychogenic adipsic patients (results are mixed and not well understood)\\n- Nasogastric tube maintenance for patients unable to complete behavioral therapy to maintain healthy fluid levels', role='assistant', function_call=None, tool_calls=None)",
    "276.2:  Acidosis": "ChatCompletionMessage(content='- Correcting the underlying problem in metabolic acidosis\\n- Infusions of bicarbonate to neutralize severe metabolic acidosis\\n- Increase alveolar ventilation through respiratory compensation (e.g., Kussmaul breathing) to reduce metabolic acid\\n- Address disturbances in the ability to excrete acid via the kidneys (e.g., in renal tubular acidosis)\\n- Mechanical ventilation for uncompensated respiratory acidosis when compensatory mechanisms are exhausted\\n- Fetal metabolic acidemia and respiratory acidemia require specialized perinatal management', role='assistant', function_call=None, tool_calls=None)",
    "276.5:  Hypovolemia": "ChatCompletionMessage(content='- **Field care:**\\n  - Identify and control the source of bleeding\\n  - Supply emergency oxygen\\n  - Support spontaneous breathing for venous return\\n  - Initiate intravenous fluids (IVs)\\n  - Employ permissive hypotension strategy\\n\\n- **Hospital treatment:**\\n  - Establish IV access\\n  - Administer oxygen as required\\n  - Infuse fresh frozen plasma or perform blood transfusion if necessary\\n  - Provide surgical repair at sites of bleeding\\n  - Avoid vasopressors like dopamine and noradrenaline in favor of fluids for correcting primary hypovolemia', role='assistant', function_call=None, tool_calls=None)",
    "276.51:  Dehydration": "ChatCompletionMessage(content='- Drinking water to restore blood plasma volume\\n- Oral rehydration therapy for mild dehydration\\n- Intravenous therapy with isotonic or hypertonic solutions for more severe dehydration\\n- Consumption of fluid replacement drinks with electrolytes (especially for athletes or those exerting themselves in hot environments)\\n- Emergency medical attention for severe cases of dehydration with symptoms such as fainting or unconsciousness', role='assistant', function_call=None, tool_calls=None)",
    "276.52:  Hypovolemia": "ChatCompletionMessage(content='- Identify and control the source of bleeding\\n- Supply emergency oxygen\\n- Use of intravenous fluids (IVs)\\n  - Infusing colloid or crystalloid IV fluids\\n- Administer blood substitutes (in development)\\n- Employ permissive hypotension strategies\\n- Fluid replacement therapy, particularly in stages 3 and 4 of hypovolemic shock\\n- Establish IV access\\n- Provide oxygen as required\\n- Fresh frozen plasma or blood transfusion when necessary\\n- Surgical repair at sites of bleeding\\n- Avoidance of vasopressors like dopamine and noradrenaline due to the risk of tissue ischemia and not addressing the primary problem', role='assistant', function_call=None, tool_calls=None)",
    "276.7:  Hyperkalemia": "ChatCompletionMessage(content='- Calcium salts\\n    - Calcium gluconate\\n    - Calcium chloride\\n- Insulin therapy with dextrose\\n    - Regular insulin\\n    - Dextrose\\n- Beta-agonist\\n    - Salbutamol (albuterol)\\n- Alkalinizing agents\\n    - Sodium bicarbonate\\n- Diuretics\\n    - Furosemide\\n    - Bumetanide\\n    - Torasemide\\n    - Chlortalidone\\n    - Hydrochlorothiazide\\n    - Chlorothiazide\\n- Potassium binders\\n    - Sodium polystyrene sulfonate with sorbitol (Kayexalate)\\n    - Patiromer\\n    - Sodium zirconium cyclosilicate\\n- Renal replacement therapy\\n    - Hemodialysis', role='assistant', function_call=None, tool_calls=None)",
    "276.8:  Hypokalemia": "ChatCompletionMessage(content=\"- Increase potassium intake through diet: \\n  - Foods rich in potassium: dried fruits (particularly apricots and figs), nuts, bran cereals, wheat germ, lima beans, molasses, leafy green vegetables, broccoli, winter squash, beets, carrots, cauliflower, potatoes, avocados, tomatoes, coconut water, citrus fruits (oranges), cantaloupe, kiwis, mangoes, bananas, red meats.\\n\\n- Oral potassium supplementation: \\n  - Mild hypokalemia (>3.0 mEq/L) treatment with potassium chloride supplements taken by mouth, either in tablet or syrup form.\\n  - Potassium bicarbonate for hypokalemia associated with metabolic acidosis.\\n\\n- Intravenous potassium replacement:\\n  - Severe hypokalemia (<3.0 mEq/L) treatment via IV supplementation typically using a saline solution with 20\u201340 meq/L KCl per liter over 3\u20134 hours.\\n  - Use of central venous catheter for solutions containing high concentrations of potassium (>40 mmol/L).\\n\\n- Potassium-sparing diuretics: \\n  - In cases of recurrent or treatment-resistant hypokalemia, medications such as amiloride, triamterene, spironolactone, or eplerenone might be used.\\n\\n- Magnesium replacement: \\n  - Necessary when hypokalemia persists despite potassium supplementation, as magnesium is a cofactor for potassium uptake.\\n\\n- Addressing the cause: \\n  - Treatment includes stopping offending medications, treating underlying medical conditions, and managing other electrolyte abnormalities.\\n\\nNote: Treatment should be personalized depending on the cause, severity, presence of symptoms, underlying conditions, and the patient's overall health status. Regular monitoring of potassium levels and cardiac function (ECG) is advised during treatment.\", role='assistant', function_call=None, tool_calls=None)",
    "277.39:  Amyloidosis": "ChatCompletionMessage(content='- High-dose melphalan followed by stem cell transplantation (for early-stage AL amyloidosis)\\n- Chemotherapy including cyclophosphamide-bortezomib-dexamethasone (for AL amyloidosis not eligible for transplant)\\n- Tumour necrosis factor (TNF)-alpha inhibitors such as infliximab and etanercept (for AA amyloidosis with inflammation)\\n- Interleukin-1 inhibitors (e.g., anakinra, canakinumab, rilonacept) if TNF-alpha inhibitors are not effective (for AA amyloidosis)\\n- Interleukin-6 inhibitors (e.g., tocilizumab) as an alternative option (for AA amyloidosis)\\n- Tafamidis (for ATTR amyloidosis, both wild type and variant)\\n- Liver transplant (previously the only effective treatment for variant ATTR amyloidosis)\\n- Diflunisal (for ATTR amyloidosis, binds to misfolded TTR protein)\\n- Inotersen (for ATTR amyloidosis, blocks gene expression of TTR)\\n- Patisiran (for ATTR amyloidosis, functions similarly to inotersen)\\n- Vutrisiran (approved by the FDA for the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults)', role='assistant', function_call=None, tool_calls=None)",
    "278.00:  Angus Barbieri's fast": "ChatCompletionMessage(content=\"Treatments mentioned for Angus Barbieri's fast:\\n\\n- Vitamins (his regimen included vitamin supplements)\\n- Electrolytes (to maintain essential mineral balance)\\n- Yeast (as a source of all essential amino acids)\\n- Tea (a zero-calorie beverage)\\n- Coffee (another zero-calorie beverage)\\n- Soda water/sparkling water (also a zero-calorie beverage)\\n- Occasional small amounts of milk (especially during the final weeks of the fast)\\n- Occasional small amounts of sugar (with his beverages, especially during the final weeks of the fast)\\n\\nPlease note that this was a medically supervised fast and should not be attempted without professional guidance.\", role='assistant', function_call=None, tool_calls=None)",
    "285.1:  Acute posthemorrhagic anemia": "ChatCompletionMessage(content='The provided text does not specifically mention any treatments for acute posthemorrhagic anemia. However, based on standard medical practice, the following treatments could be considered for acute posthemorrhagic anemia:\\n\\n- Immediate blood transfusion to replace lost blood volume and hemoglobin\\n- Intravenous fluids to maintain blood pressure and volume while preparing for blood transfusion\\n- Oxygen therapy to ensure adequate oxygenation of tissues\\n- Iron supplementation to help the body replenish red blood cells after acute blood loss\\n- Monitoring and treatment of potential coagulopathy (bleeding disorder) if present\\n- Surgical or interventional procedures to control ongoing bleeding if the source is identifiable and accessible\\n- Supportive care, including bed rest and monitoring of vital signs and hemodynamic status', role='assistant', function_call=None, tool_calls=None)",
    "285.21:  Chronic kidney disease": "ChatCompletionMessage(content=\"- Medications to lower blood pressure\\n  - Angiotensin converting enzyme inhibitors (ACEIs)\\n  - Angiotensin II receptor antagonists (ARBs)\\n- Loop diuretics (for edema and additional blood pressure control)\\n- Medications for blood sugar control (in diabetic patients)\\n- Medications for cholesterol management\\n- Staying active and certain dietary changes\\n  - Low-salt diet\\n  - Right amount of protein\\n\\n- Treatments for complications:\\n  - Anemia management\\n    - Erythropoietin replacement\\n    - Iron supplementation (oral or intravenous)\\n  - Bone disease management\\n    - Phosphate binders\\n    - Calcitriol or vitamin D supplements\\n\\n- For severe disease:\\n  - Hemodialysis\\n  - Peritoneal dialysis\\n  - Kidney transplant\\n\\n- Lifestyle interventions:\\n  - Weight loss for overweight or obese individuals\\n  - Reduced dietary salt intake\\n  - Omega-3 fatty acid supplementation\\n  - Protein supplementation\\n\\n- Management for sleep disorders in CKD patients (though evidence of effectiveness is limited)\\n\\n- eHealth interventions to improve dietary sodium intake and fluid management (limited evidence)\\n\\n- Kidney replacement therapies in advanced stages:\\n  - Maintenance dialysis\\n  - Kidney transplantation\\n\\nPlease note that the list here is a representation of treatments mentioned in the provided text and is not exhaustive. Clinical guidelines may have evolved, and the management of CKD is personalized to each individual's needs. Regular follow-up with healthcare providers is essential for optimal management of CKD.\", role='assistant', function_call=None, tool_calls=None)",
    "286.7:  Factor XII": "ChatCompletionMessage(content='From the provided text, there are no explicit treatments detailed for Factor XII deficiency itself as it is usually asymptomatic and does not result in bleeding. However, there are mentions of interventions or aspects that relate to the function or the modulation of Factor XII activity:\\n\\n- **Targeting polyphosphates with phosphatases**: This can interfere with the procoagulant activity of activated platelets and potentially block platelet-induced thrombosis.\\n   \\n- **Factor XII inhibitors**: Development of Factor XII inhibitors as potential drugs, with some in clinical trials, aiming to provide safe anticoagulant effects without increasing bleeding risk.\\n\\n- **Use of materials that activate Factor XII in emergency treatments**: Kaolinite, a type of clay, is used in QuikClot products to activate Factor XII and promote blood clotting in situations such as penetrating trauma.\\n\\nThese are interventions mentioned in context of research, clinical trials, or emergency hematologic interventions rather than standard treatments specifically for Factor XII deficiency.', role='assistant', function_call=None, tool_calls=None)",
    "289.59:  Wandering spleen": "ChatCompletionMessage(content='- Splenopexy (fixation of the spleen)\\n- Splenectomy (surgical removal of the spleen), if there is no blood flow after detorsion\\n- Laparoscopic surgery (as an effective surgical technique for splenopexy or splenectomy)', role='assistant', function_call=None, tool_calls=None)",
    "291.0:  Delirium tremens": "ChatCompletionMessage(content='### Treatments for Delirium Tremens:\\n\\n- Avoidance of alcohol as part of a prevention strategy\\n- Controlled tapering off of the precipitating substance using similarly acting compounds\\n- Care within a quiet intensive care unit environment\\n- Benzodiazepines\\n  - Diazepam\\n  - Lorazepam\\n  - Chlordiazepoxide\\n  - Oxazepam\\n- Administration of benzodiazepines to achieve light sedation\\n- Adjunctive non-benzodiazepine medications for sleep disturbance\\n- Antipsychotics\\n  - Haloperidol (as a major tranquilizer to combat overactivity)\\n- Intramuscular administration of thiamine \\n- Intravenous administration of thiamine in high doses\\n- Treatment of any associated electrolyte abnormalities\\n- Addressing possible underlying conditions such as pancreatitis or alcoholic hepatitis\\n- Treatment for status epilepticus, if it occurs\\n- Well-lit room provision to help alleviate hallucinations\\n- Historical mention of alcoholic beverages to manage symptoms (not universally supported)\\n\\nPlease note that the list provided above is a summary of the treatments mentioned for delirium tremens within the text. Actual treatment should always be personalized and administered by a healthcare professional based on individual patient needs and current medical guidelines.', role='assistant', function_call=None, tool_calls=None)",
    "291.81:  Alcohol withdrawal syndrome": "ChatCompletionMessage(content='- Benzodiazepines (e.g., chlordiazepoxide, diazepam, lorazepam)\\n- Thiamine (vitamin B1)\\n- Folic acid\\n- Pyridoxine (vitamin B6)\\n- Multivitamin preparations\\n- Electrolyte correction\\n- Anticonvulsants (e.g., topiramate, pregabalin, gabapentin, carbamazepine)\\n- Clonidine\\n- Beta blockers (for hypertension)\\n- Antipsychotics (e.g., haloperidol) with caution\\n- Naltrexone, acamprosate, and disulfiram (for prevention of further drinking, post-withdrawal)\\n- Magnesium or trazodone (for treatment of insomnia in protracted withdrawal)', role='assistant', function_call=None, tool_calls=None)",
    "293.0:  Impulse-control disorder": "ChatCompletionMessage(content='- **Medication Treatments:**\\n  - Fluvoxamine and clomipramine for pathological gambling\\n  - Clomipramine for trichotillomania\\n  - Fluoxetine for pathological skin picking disorder and Intermittent Explosive Disorder (IED)\\n  - Paroxetine with variable effectiveness\\n  - Escitalopram for pathological gambling with anxiety symptoms\\n\\n- **Psychosocial Treatments:**\\n  - Cognitive Behavioral Therapy (CBT) for pathological gambling, sexual addiction, and child pyromaniacs\\n  - Cognitive Relaxation and Coping Skills Therapy (CRCST) for Intermittent Explosive Disorder\\n  - Covert sensitization, imaginal desensitization, systematic desensitization, aversion therapy, relaxation training, and alternative sources of satisfaction for kleptomania\\n  - Exposure and response prevention, relapse prevention, cognitive restructuring, covert sensitization, and stimulus control for compulsive buying', role='assistant', function_call=None, tool_calls=None)",
    "305.1:  Nicotine dependence": "ChatCompletionMessage(content='- Nicotine Replacement Therapy (NRT)\\n  - Nicotine gum\\n  - Nicotine inhaler\\n  - Nicotine lozenge/mini-lozenge\\n  - Nicotine nasal spray\\n  - Nicotine patch\\n  \\n- Prescription medications\\n  - Bupropion\\n  - Varenicline\\n  - Cytisine (not approved in some countries)\\n  \\n- Behavioral Counseling\\n  - In-person interventions (individual or group)\\n  - Phone-based interventions, including mobile phone interventions\\n  \\n- Vaccine (under development)\\n  - TA-NIC vaccine to create anti-nicotine antibodies\\n\\nCombination therapies of medications and psychosocial interventions may increase the likelihood of successful quitting.', role='assistant', function_call=None, tool_calls=None)",
    "311:  Impulse-control disorder": "ChatCompletionMessage(content='- Psychosocial treatments:\\n  - Cognitive-behavioral therapy (CBT) for pathological gambling and sexual addiction\\n  - Cognitive-behavioral therapy for child pyromaniacs\\n  - Cognitive Relaxation and Coping Skills Therapy (CRCST) for Intermittent explosive disorder\\n  - Cognitive behavior techniques for kleptomania, including covert sensitization, imaginal desensitization, systematic desensitization, aversion therapy, relaxation training, and seeking alternative sources of satisfaction\\n  - Cognitive behavior therapy techniques for compulsive buying, including exposure and response prevention, relapse prevention, cognitive restructuring, covert sensitization, and stimulus control\\n\\n- Pharmacological treatments:\\n  - Fluvoxamine and clomipramine for pathological gambling\\n  - Clomipramine for trichotillomania\\n  - Fluoxetine for pathological skin picking disorder and demonstrated significant improvement in reducing frequency and severity of impulsive aggression and irritability in Intermittent explosive disorder\\n  - Paroxetine showing some effectiveness (results are inconsistent)\\n  - Escitalopram improving the condition of subjects with pathological gambling with anxiety symptoms', role='assistant', function_call=None, tool_calls=None)",
    "327.23:  Obstructive sleep apnea": "ChatCompletionMessage(content='* Continuous Positive Airway Pressure (CPAP)\\n* Mandibular Advancement Devices (MADs)\\n* Physical training\\n* Weight loss\\n* Tonsillectomy and adenoidectomy (in children)\\n* Rapid Palatal Expansion (in children)\\n* Maxillomandibular advancement\\n* Uvulopalatopharyngoplasty (UPPP)\\n* Septoplasty\\n* Turbinectomy\\n* Genioglossus advancement\\n* Hyoid suspension\\n* Upper airway stimulation system (neurostimulation)\\n* Radiofrequency ablation (RFA)\\n* Lifestyle changes (avoiding alcohol, smoking, and certain medications)\\n* Oral appliances / functional orthopedic appliances (in children)\\n* Surgical removal of enlarged tonsils and adenoids (in children)', role='assistant', function_call=None, tool_calls=None)",
    "348.39:  Encephalopathy": "ChatCompletionMessage(content='- Anticonvulsants to reduce or halt seizures\\n- Dietary changes and nutritional supplements\\n- Dialysis for severe cases (e.g., uremic encephalopathy)\\n- Organ replacement surgery (e.g., liver transplant for hepatic encephalopathy)\\n- Sympathomimetic drugs for encephalopathy caused by brain injury, chronic infections, strokes, brain tumors\\n- Gluten-free diet for encephalopathy caused by untreated celiac disease or non-celiac gluten sensitivity', role='assistant', function_call=None, tool_calls=None)",
    "349.82:  Toxic encephalopathy": "ChatCompletionMessage(content='- Immediate removal from exposure to the toxic substance(s)\\n- Treatment for depression if present\\n- Counseling for coping strategies\\n- Diet changes and nutritional supplements\\n- Prescription of anticonvulsants for seizure reduction or control\\n- Dialysis or organ replacement surgery in severe cases\\n- Lifelong abstinence from alcohol (in the case of alcohol-induced toxic encephalopathy)\\n- Standardized imaging and neuropsychological testing for diagnosis and management\\n- Screening for heavy metals and other toxins', role='assistant', function_call=None, tool_calls=None)",
    "357.2:  Polyneuropathy": "ChatCompletionMessage(content='- Ascertain and manage the underlying cause\\n- Weight decrease\\n- Use of a walking aid\\n- Occupational therapist assistance\\n- Blood pressure control, especially for those with diabetes\\n- Intravenous immunoglobulin, used for multifocal motor neuropathy and chronic inflammatory demyelinating polyneuropathy (CIDP)\\n- Methylprednisolone, indicated as a viable treatment for CIDP\\n- Avoidance or limitation of corticosteroids in the treatment of critical illness polyneuropathy', role='assistant', function_call=None, tool_calls=None)",
    "357.82:  Critical illness polyneuropathy": "ChatCompletionMessage(content='The text provided above discusses the nature of Critical Illness Polyneuropathy (CIP) and introduces concepts around its causes, diagnosis, and general information, but it does not provide specific treatments. However, based on clinical knowledge, treatments for CIP are typically supportive and may include the following:\\n\\n- **Minimizing the use of potential contributory drugs**: Avoiding or carefully using certain medications such as corticosteroids and neuromuscular blocking agents, which may contribute to the development of CIP and CIM.\\n  \\n- **Blood sugar control**: Managing blood glucose levels to prevent sustained hyperglycemia, which is also thought to be a contributing factor in CIP/CIM.\\n  \\n- **Physiotherapy and rehabilitation**: Early mobilization and physical therapy help prevent muscle atrophy due to prolonged immobilization and may improve recovery.\\n  \\n- **Optimization of nutrition**: Ensuring adequate nutritional support to address the catabolic state that critically ill patients often experience.\\n  \\n- **Management of underlying conditions**: Treating the primary illness causing the critical state, such as sepsis or multi-organ failure, which may indirectly help in the management of CIP.\\n\\nIt\u2019s important to note that there is no specific curative treatment for CIP. Management largely focuses on supportive care and addressing the risk factors and underlying causes that might contribute to the development or prolongation of the disease.', role='assistant', function_call=None, tool_calls=None)",
    "362.21:  Retinopathy of prematurity": "ChatCompletionMessage(content='- **Peripheral retinal ablation** via laser photocoagulation\\n- Use of **cryotherapy** for retinal ablation (less preferred when laser treatment is available due to side effects)\\n- **Scleral buckling** and/or **vitrectomy surgery** for severe ROP (stages 4 and 5)\\n- **Intravitreal injection of bevacizumab (Avastin)** as a supportive measure in aggressive posterior ROP\\n- **Oral propranolol** treatment for counteracting the progression of ROP (under evaluation, safety concerns exist)', role='assistant', function_call=None, tool_calls=None)",
    "379.21:  Vitreous body": "ChatCompletionMessage(content='The provided text discusses the nature and structure of the vitreous body but does not explicitly mention any treatments for the vitreous body. Since it is purely informational regarding the anatomy, development, and certain clinical aspects of the vitreous body, treatments cannot be extracted from this text. If you have clinical conditions in mind, such as vitreous detachment or floaters, treatments for those specific conditions can be provided separately.', role='assistant', function_call=None, tool_calls=None)",
    "401.9:  Pulmonary hypertension": "ChatCompletionMessage(content=\"Treatments for pulmonary hypertension mentioned in the provided text include:\\n\\n- Oxygen therapy\\n- Diuretics\\n- Medications to inhibit blood clotting\\n- Epoprostenol (prostaglandin I2, synthetic prostacyclin)\\n- Treprostinil\\n- Iloprost\\n- Bosentan (endothelin receptor antagonist)\\n- Ambrisentan\\n- Macitentan\\n- Sildenafil (phosphodiesterase type 5 inhibitor)\\n- Tadalafil (phosphodiesterase type 5 inhibitor)\\n- Selexipag\\n- Riociguat (soluble guanylate cyclase activator)\\n- Lung transplantation\\n- Atrial septostomy (a surgical procedure that relieves pressure on the right side of the heart)\\n- Pulmonary thromboendarterectomy (PTE - a surgical procedure to remove an organized thrombus from the pulmonary artery)\\n\\nIt's also noted that exercise-based rehabilitation may lead to an increase in exercise capacity and an improvement in health-related quality of life without significantly increasing adverse events.\", role='assistant', function_call=None, tool_calls=None)",
    "411.1:  Angioplasty": "ChatCompletionMessage(content='- Balloon angioplasty\\n- Percutaneous coronary intervention (PCI) with stenting\\n- Peripheral angioplasty\\n- Peripheral stenting\\n- Atherectomy (occasionally used in conjunction with peripheral angioplasty)\\n- Renal artery angioplasty, with or without stenting\\n- Carotid angioplasty and carotid stenting\\n- Drug-coated balloon angioplasty\\n- Deep venous stenting (for obstructive chronic venous disease)\\n- Seldinger technique for vascular access\\n- Fluoroscopic guidance for catheter and wire placement\\n- Use of drug-eluting stents to combat in-stent restenosis\\n- Dual antiplatelet therapy (DAPT) post-procedure with clopidogrel and aspirin\\n- Excimer laser coronary angioplasty (ELCA) for undilatable and uncrossable lesions', role='assistant', function_call=None, tool_calls=None)",
    "412:  Myocardial infarction diagnosis": "ChatCompletionMessage(content='- Electrocardiogram (ECG) monitoring and interpretation\\n- Measurement of cardiac markers/biomarkers (e.g., troponins, creatine kinase-MB)\\n- Coronary angiography\\n- Coronary angioplasty as a therapeutic measure\\n- Supportive treatments, such as oxygen administration, pain relief, and treatment for shock if present\\n\\nPlease note, this list focuses on the diagnostic and direct interventional treatments mentioned and does not cover all potential treatments such as medications (e.g., antiplatelet drugs, thrombolytics, beta-blockers, ACE inhibitors), lifestyle changes, or long-term management strategies.', role='assistant', function_call=None, tool_calls=None)",
    "414.01:  Coronary artery bypass surgery": "ChatCompletionMessage(content='Treatments for Coronary Artery Bypass Surgery:\\n\\n- **Standard on-pump coronary artery bypass graft (CABG) using cardiopulmonary bypass machine**\\n  - Harvesting arteries or veins for grafts\\n  - Performing surgical anastomosis to bypass narrowings\\n  - Utilizing harvested left internal mammary artery for LAD\\n  - Possible use of right internal mammary artery, radial artery, or great saphenous vein\\n\\n- **Off-pump coronary artery bypass graft (OPCABG)**\\n  - Anastomoses constructed while the heart is beating\\n  - Use of techniques to stabilize the heart during the procedure\\n\\n- **Management of complications**\\n  - Treatment for bleeding, heart problems, stroke, infections, and kidney injury\\n\\n- **Preoperative examination and strategy development**\\n  - Routine preoperative system and organ status checks\\n  - Stopping certain medications (e.g., anticoagulants) to prevent bleeding\\n  - Planning which coronary arteries to bypass\\n\\n- **Emergency CABG in case of myocardial infarction**\\n  - Use of intra-aortic balloon pump (IABP) preoperatively\\n  - Rapid establishment of cardiopulmonary bypass\\n  - Revascularization with saphenous veins\\n\\n- **Use of alternative arterial grafts**\\n  - Exploring grafts from other arteries when ITAs are not an option\\n\\n- **Minimally invasive and robot-assisted techniques**\\n  - MIDCAB and robot-assisted coronary revascularization to avoid a large sternum incision\\n\\n- **Postoperative care**\\n  - Administration of medications such as beta blockers, aspirin, ACE inhibitors, and calcium channel blockers\\n  - Monitoring and management in ICU\\n  - Recommendation of tailored exercise plans after discharge\\n\\n- **Long-term patient management**\\n  - Follow-up on graft patency\\n  - Continued medical management for cardiovascular risk reduction\\n\\n- **Comparative approaches**\\n  - CABG vs. Percutaneous Coronary Intervention (PCI) in certain patient populations\\n\\nPlease note that the text above does not provide specific details on post-operative medications or patient education, which are also important aspects of CABG treatment.', role='assistant', function_call=None, tool_calls=None)",
    "415.0:  Pulmonary heart disease": "ChatCompletionMessage(content='- Antibiotics (if there is a concomitant infection)\\n- Expectorants (to help clear mucus from the lungs)\\n- Oxygen therapy (to improve oxygenation and ease right heart failure)\\n- Diuretics (to decrease strain on the heart)\\n- Digitalis (to improve heart contractility)\\n- Vasodilators (to relax blood vessels, though not widely recommended according to NICE)\\n- Bronchodilators (when wheezing is present)\\n- Anticoagulants (when venous thromboembolism is present)\\n- Venesection (in severe secondary polycythemia due to hypoxia)\\n- Lung transplantation (as a last resort in extreme cases)', role='assistant', function_call=None, tool_calls=None)",
    "416.8:  Pulmonary heart disease": "ChatCompletionMessage(content='- Antibiotics\\n- Expectorants\\n- Oxygen therapy\\n- Diuretics\\n- Digitalis\\n- Vasodilators\\n- Anticoagulants\\n- Shenmai injection (in conjunction with conventional treatments)\\n- Bronchodilators\\n- Calcium channel blockers (though not recommended by NICE and effective only in a minority of cases)\\n- Venesection (for severe secondary polycythemia due to hypoxia)\\n- Lung transplantation (single/double lung in extreme cases)', role='assistant', function_call=None, tool_calls=None)",
    "416.9:  Chronic obstructive pulmonary disease": "ChatCompletionMessage(content='The treatments for Chronic obstructive pulmonary disease (COPD) mentioned in the provided text include:\\n\\n- Smoking cessation\\n- Vaccinations (e.g., annual influenza vaccinations and pneumococcal vaccination)\\n- Pulmonary rehabilitation\\n- Inhaled bronchodilators\\n- Inhaled corticosteroids\\n- Long-term oxygen therapy\\n- Lung volume reduction\\n- Lung transplantation\\n- Antibiotics (for periods of acute worsening)\\n- Administration of corticosteroids (for periods of acute worsening)\\n- Hospitalization (for periods of acute worsening)', role='assistant', function_call=None, tool_calls=None)",
    "424.0:  Valvular heart disease": "ChatCompletionMessage(content=\"- Medication alone\\n  - Antibiotics (in specific situations for endocarditis prophylaxis)\\n  - Antithrombotic medications (such as aspirin)\\n  - Anticoagulants\\n  - Diuretics\\n\\n- Surgical valve repair\\n- Valve replacement \\n\\n- Aortic stenosis\\n  - Aortic valve replacement (AVR)\\n  - Trans-catheter Aortic Valve Replacement (TAVR) for high-risk patients\\n  \\n- Aortic regurgitation\\n  - Aortic valve replacement, especially if severe with left ventricular ejection fraction less than 50%\\n  - Anti-hypertensive medications such as calcium channel blockers, ACE inhibitors, or ARBs\\n\\n- Mitral stenosis\\n  - Percutaneous balloon mitral valvuloplasty (PBMV)\\n  - Mitral valve surgery (replacement, repair, commisurotomy)\\n  - Anticoagulation for patients with atrial fibrillation or previous embolic events\\n\\n- Mitral regurgitation\\n  - Surgery (mitral valve repair preferred to replacement)\\n  - Medications including vasodilators, diuretics, digoxin, antiarrhythmics, and chronic anticoagulation\\n\\nIt's important to note that some aspects of treatment, like avoiding smoking and excessive alcohol consumption or taking water pills (diuretics), are not explicitly mentioned in the provided text as specific treatments for valvular heart disease but are considered general measures to manage cardiovascular health.\", role='assistant', function_call=None, tool_calls=None)",
    "424.1:  Valvular heart disease": "ChatCompletionMessage(content='- Avoidance of smoking and excessive alcohol consumption\\n- Antibiotic prophylaxis (for specific procedures in at-risk patients)\\n- Antithrombotic medications such as aspirin\\n- Anticoagulants (for patients with atrial fibrillation or previous embolic events)\\n- Balloon dilation (e.g., percutaneous balloon mitral valvuloplasty for mitral stenosis)\\n- Diuretics (to treat pulmonary congestion or edema)\\n\\n**Aortic Stenosis:**\\n- Aortic valve replacement (AVR) surgery (for severe symptomatic stenosis)\\n- Transcatheter Aortic Valve Replacement (TAVR) (for high-risk patients)\\n- Management of angina with short-acting nitrovasodilators, beta-blockers, and/or calcium channel blockers\\n- Aggressive treatment of hypertension, with caution on the use of beta-blockers\\n- Heart failure management with digoxin, diuretics, nitrovasodilators, and ACE inhibitors (if not contraindicated)\\n\\n**Aortic Regurgitation:**\\n- Aortic valve replacement (for severe symptomatic aortic regurgitation or evidence of left ventricular dysfunction)\\n- Treatment of hypertension with calcium channel blockers, ACE inhibitors, or ARBs\\n- Endocarditis prophylaxis for at-risk procedures\\n\\n**Mitral Stenosis:**\\n- Percutaneous balloon mitral valvuloplasty (PBMV) (for symptomatic severe mitral stenosis)\\n- Mitral valve surgery (if PBMV fails or is not feasible, may include valve replacement, repair, or commissurotomy)\\n- Anticoagulation therapy (for patients with atrial fibrillation or a previous embolic event)\\n\\n**Mitral Regurgitation:**\\n- Surgical intervention (for chronic severe mitral regurgitation in symptomatic patients or asymptomatic patients with compromised left ventricular function)\\n- Mitral leaflet repair preferred to valve replacement (if feasible)\\n- Medical management with vasodilators, diuretics, digoxin, antiarrhythmics, and anticoagulation\\n\\n**Special Considerations for Pregnancy:**\\n- Evaluation of maternal and fetal risks\\n- Management tailored to the severity of valvular lesions and associated symptoms\\n- Consideration of anticoagulation therapy for patients with mechanical prosthetic valves\\n\\n(The above treatments are extracted and restructured in list format from the given text. It is crucial to assess each case individually and consult with a specialist for tailored management plans.)', role='assistant', function_call=None, tool_calls=None)",
    "425.4:  Cardiomyopathy": "ChatCompletionMessage(content='- Lifestyle changes\\n- Medications (which may be considered conservative treatment)\\n- Iatrogenic/implanted pacemakers for slow heart rates\\n- Defibrillators for those prone to fatal heart rhythms\\n- Ventricular assist devices (VADs) for severe heart failure\\n- Catheter ablation for recurring dysrhythmias that cannot be eliminated by medication or mechanical cardioversion\\n- Heart transplant (for some patients may eventually be required)', role='assistant', function_call=None, tool_calls=None)",
    "427.1:  Ventricular tachycardia": "ChatCompletionMessage(content='- Antiarrhythmic medication procainamide for individuals with normal blood pressure and strong pulse\\n- Immediate cardioversion, preferably with a biphasic DC shock of 200 joules\\n- Cardiopulmonary resuscitation (CPR) and defibrillation for those in cardiac arrest due to ventricular tachycardia\\n- Precordial thump (reserved for those with prior experience) for witnessed unstable ventricular tachycardia while on a heart monitor\\n- Implantable cardiac defibrillator (ICD) for prevention of recurrence\\n- Medications such as calcium channel blockers\\n- Antiarrhythmic medications: \\n  - Amiodarone (no evidence available supporting its superiority over procainamide)\\n  - Magnesium sulfate for torsades de pointes or suspected low blood magnesium levels\\n- Long-term anti-arrhythmic therapy with:\\n  - Beta-blockers like carvedilol, metoprolol, and bisoprolol\\n  - Potassium-Channel-Blockers like dronedarone, bretylium, sotalol, ibutilide, and dofetilide\\n  - Angiotensin-converting enzyme (ACE) inhibitors\\n  - Aldosterone antagonists\\n- Catheter ablation as a definitive treatment option for recurrent VT\\n- Remote magnetic navigation for catheter ablation procedures', role='assistant', function_call=None, tool_calls=None)",
    "427.31:  Atrial fibrillation": "ChatCompletionMessage(content='- Healthy lifestyle changes\\n  - Weight loss for people with obesity\\n  - Increased physical activity\\n  - Drinking less alcohol\\n  \\n- Medications for rate control\\n  - Beta blockers\\n  - Non-dihydropyridine calcium channel blockers (e.g., diltiazem, verapamil)\\n  - Digitalis or digoxin\\n\\n- Medications for rhythm control\\n  - Amiodarone\\n  - Dronedarone\\n  - Procainamide\\n  - Dofetilide\\n  - Sotalol\\n  - Flecainide\\n  - Propafenone\\n\\n- Electrical cardioversion\\n\\n- Catheter ablation\\n\\n- Anticoagulation therapy\\n  - Warfarin\\n  - Direct oral anticoagulants (DOACs) such as dabigatran, rivaroxaban, edoxaban, apixaban\\n\\n- Left atrial appendage occlusion therapy', role='assistant', function_call=None, tool_calls=None)",
    "427.32:  Atrial flutter": "ChatCompletionMessage(content='- Administration of adenosine intravenously\\n- Beta blockers (e.g., metoprolol)\\n- Calcium channel blockers (e.g., diltiazem)\\n- Urgent electrical shock (cardioversion) for unstable atrial flutter\\n- Long-term use of blood thinners (anticoagulants, e.g., warfarin or apixaban)\\n- Antiarrhythmics (e.g., ibutilide) for rhythm control\\n- Catheter ablation for definitive treatment', role='assistant', function_call=None, tool_calls=None)",
    "428.23:  Heart failure": "ChatCompletionMessage(content='The treatments for heart failure mentioned in the text are:\\n\\n- Lifestyle changes:\\n  - Not smoking\\n  - Physical exercise\\n  - Dietary changes\\n\\n- Medications:\\n  - Angiotensin-converting-enzyme inhibitors (ACE inhibitors)\\n  - Angiotensin receptor blockers (ARBs)\\n  - Angiotensin receptor-neprilysin inhibitors (ARNIs)\\n  - Beta blockers\\n  - Mineralocorticoid receptor antagonists (MRAs)\\n  - Sodium-glucose cotransporter 2 inhibitors (SGLT2 inhibitors)\\n  - Diuretics\\n\\n- Implanted devices and therapies:\\n  - Pacemaker\\n  - Implantable cardiac defibrillator\\n  - Cardiac resynchronization therapy (CRT)\\n  - Cardiac contractility modulation (CCM)\\n\\n- Advanced treatments for severe disease:\\n  - Cardiac assist devices\\n  - Ventricular assist device (VAD)\\n  - Heart transplantation\\n\\n- Iron supplementation for iron deficiency\\n- Palliative care for symptom management and advanced care planning\\n- Monitoring and evaluation through clinical prediction rules and cardiopulmonary exercise testing\\n\\nPlease note that the specific treatment plan for an individual patient with heart failure would be tailored to their unique situation, considering factors such as the cause of their heart failure, the type of heart failure (reduced ejection fraction, preserved ejection fraction, etc.), comorbid conditions, and other factors.', role='assistant', function_call=None, tool_calls=None)",
    "428.32:  Heart failure with preserved ejection fraction": "ChatCompletionMessage(content='The text provides detailed information about Heart failure with preserved ejection fraction (HFpEF) but does not specifically list treatments in a bulleted format. Based on the content, the following treatments for HFpEF can be inferred:\\n\\n- Treatment aimed at symptom relief and management of comorbid conditions\\n- Use of diuretics to manage volume overload\\n- Management of commonly associated conditions such as atrial fibrillation, coronary artery disease, hypertension, and hyperlipidemia\\n- Exercise interventions to improve physical capacity and potentially improve left ventricular diastolic function\\n- Management of behavioral factors, such as avoiding alcohol, smoking, and high sodium intake\\n\\n**Pharmacologic therapy:**\\n- Mineralocorticoid receptor antagonists (e.g., Spironolactone)\\n- Beta blockers (e.g., nebivolol)\\n- Angiotensin-converting enzyme (ACE) inhibitors (e.g., enalapril, ramipril)\\n- Angiotensin II receptor blockers (ARBs)\\n- Calcium channel blockers (e.g., verapamil)\\n- Diuretics for congestion management\\n- SGLT2 inhibitors (with a class 2a recommendation according to the 2022 ACC/AHA/HFSA Guideline)\\n\\n**Experimental therapies:**\\n- Self-expanding devices that attach to the external surface of the left ventricle (ImCardia and CORolla TAA under investigation)\\n\\nPlease note that the information provided should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding HFpEF or any other medical condition.', role='assistant', function_call=None, tool_calls=None)",
    "428.33:  Acute decompensated heart failure": "ChatCompletionMessage(content=\"- **Oxygen Administration**: Supplemental oxygen for low blood oxygen levels; not recommended for routine use.\\n  \\n- **Diuretics**: Intravenous loop diuretics like furosemide; in cases of diuretic resistance, use of bumetanide, possibly combined with thiazide diuretics such as metolazone or chlorothiazide.\\n\\n- **Vasodilators**:\\n  - Nitrates such as nitroglycerin and isosorbide dinitrate for initial therapy.\\n  - Nesiritide with caution and only if conventional therapy is ineffective or contraindicated.\\n\\n- **ACE inhibitors**: Used with caution and not initiated during acute decompensation, particularly in individuals with poor kidney perfusion.\\n\\n- **Angiotensin Receptor Blockers (ARBs)**: Similar caution as ACE inhibitors in the context of acute decompensation.\\n\\n- **Beta-blockers**: They may be decreased or stopped in cases of low blood pressure.\\n\\n- **Inotropic Agents**: Used in cases of low blood pressure (SBP < 90 mmHg) to support cardiac output.\\n\\n- **Opioids**: Historically used for acute pulmonary edema but not commonly recommended due to lack of supporting evidence.\\n\\n- **Morphine**: Though mentioned, there's no affirmation of its use in the treatment in the text provided.\\n\\n- **Non-Invasive Positive Pressure Ventilation (NIPPV)**: Including continuous positive airway pressure (CPAP) for improving symptoms and potentially reducing mortality.\\n\\n- **Mechanical Ventilation**: For severe respiratory failure requiring endotracheal intubation.\\n\\n- **Ultrafiltration**: For fluid removal in ADHF patients with kidney failure, particularly to reduce long-term hospitalization rate.\\n\\n- **Surgical Intervention**: In cases of acute aortic regurgitation, ventricular aneurysm rupture, and cardiac tamponade, and for heart valve repair/replacement, coronary artery bypass grafting (CABG), or heart transplantation.\\n\\n- **Angioplasty**: To improve symptoms of coronary artery disease (CAD) and reduce damage post-heart attack.\\n\\n- **Pacemakers**: To treat abnormal heart rhythms contributing to heart failure.\\n\\nPlease note that while the text outlines various treatments, specific interventions should be personalized for each patient based on clinical judgment, considering the patient\u2019s hemodynamic status, underlying causes, and co-morbidities.\", role='assistant', function_call=None, tool_calls=None)",
    "430:  Subarachnoid hemorrhage": "ChatCompletionMessage(content='* Prompt neurosurgery or endovascular coiling\\n* Medications such as labetalol to lower blood pressure\\n* Treatment of fevers\\n* Use of Nimodipine, a calcium channel blocker, to prevent vasospasm\\n* Routine use of medications to prevent further seizures is of unclear benefit\\n* External ventricular drain (EVD) placement in certain cases\\n* Maintaining systolic blood pressure between 140 and 160 mmHg\\n* Urgent surgical removal of blood or occlusion of the bleeding site for those with certain conditions on CT scan\\n* Clipping or coiling to reduce the risk of rebleeding from a cerebral aneurysm\\n* Calcium channel blockers to prevent vasospasm\\n* Transcranial Doppler screening for vasospasm development\\n* Treatment with a \"triple H\" protocol (hypertension, hypervolemia, hemodilution) for symptomatic vasospasm\\n* Angiography and potential administration of vasodilator medication directly into the artery for persistent delayed ischemia\\n* Interventional angioplasty for treatment-resistant vasospasm\\n* Therapeutic lumbar puncture or ventricular drain to relieve acute hydrocephalus\\n* Prevention of deep vein thrombosis with compression stockings or intermittent pneumatic compression\\n* Pain management with non-sedating agents like codeine\\n* Prevention of complications such as pneumonia, cardiac decompensation, and electrolyte imbalance\\n* Nutritional support preferably via mouth or nasogastric tube\\n* Use of bladder catheter for fluid balance monitoring\\n* Possible benzodiazepines for distress\\n* Administration of antiemetic drugs to manage vomiting\\n* Prophylactic antiepileptic medications for seizure prevention, although use is controversial', role='assistant', function_call=None, tool_calls=None)",
    "431:  Intracerebral hemorrhage": "ChatCompletionMessage(content='- Care in an intensive care unit\\n- Strict blood pressure control with frequent use of both pressors and antihypertensive agents\\n- Reversal of anticoagulation if applicable\\n- Maintenance of normal blood sugar levels\\n- Possible placement of an external ventricular drain\\n- Avoidance of corticosteroid use\\n- Surgical removal of the blood if indicated\\n- Rapid lowering of blood pressure using antihypertensive therapy\\n- Administration of Factor VIIa within 4 hours to limit bleeding (with consideration of thromboembolism risks)\\n- Administration of frozen plasma, vitamin K, protamine, or platelet transfusions in case of coagulopathy\\n- Use of specific reversal agents such as idarucizumab and andexanet alfa for patients on direct oral anticoagulants, or prothrombin complex concentrate if specific agents are not available\\n- Anticonvulsant administration reserved for those with clinical seizures or seizure activity on EEG\\n- Administration of H2 antagonists or proton pump inhibitors for stress ulcer prevention\\n- Surgical interventions such as aspiration by stereotactic surgery, endoscopic drainage, or craniectomy depending on hematoma size, location, and patient condition', role='assistant', function_call=None, tool_calls=None)",
    "432.1:  Subdural hematoma": "ChatCompletionMessage(content='- Careful monitoring for small subdural hematomas that may resorb naturally\\n- Inserting a small catheter to drain the hematoma through a burr hole in the skull\\n- Craniotomy for large or symptomatic hematomas to open the skull, remove the clot, and control bleeding\\n- Postoperative management of complications such as increased intracranial pressure, brain edema, new or recurrent bleeding, infection, and seizures\\n- Potential use of anticonvulsants in patients with a history of seizures (unclear if beneficial in those without a history of seizures)\\n- Conservative medication treatment for chronic subdural hematoma, which may include:\\n  - Atorvastatin (an HMG-CoA reductase inhibitor) to reduce hematoma volume and improve neurological function\\n  - Dexamethasone, especially in conjunction with surgical drainage, to reduce recurrence rate\\n  - Mannitol (evidence supporting conservative treatment is still weak)\\n- Management of high recurrence rates through possibly predictive grading scales for patients at risk of chronic subdural hematoma recurrence (e.g., the Puerto Rico Recurrence Scale)', role='assistant', function_call=None, tool_calls=None)",
    "437.0:  Cerebral atherosclerosis": "ChatCompletionMessage(content='- Over-the-counter platelet inhibitors like aspirin for asymptomatic individuals with intracranial stenosis\\n- Prescribed anti-coagulation medications for those with symptomatic presentation\\n- Endovascular treatment options for severe stenosis:\\n  - Angioplasty\\n  - Stent insertion\\n  - Bypass surgery of the blocked area', role='assistant', function_call=None, tool_calls=None)",
    "458.29:  Cerebrospinal fluid leak": "ChatCompletionMessage(content=\"Based on the provided text, here is a bulleted list of treatments for cerebrospinal fluid (CSF) leak:\\n\\n**Conservative Treatments:**\\n- Analgesics for pain management \\n- Rest \\n- Increased caffeine intake (either orally or intravenous caffeine infusion)\\n- Hydration \\n- Corticosteroids (for transient relief) \\n- Use of an abdominal binder to increase intracranial pressure temporarily\\n\\n**Epidural Blood Patch:**\\n- Injection of the patient's own blood at the site of the CSF leak\\n- An initial lumbar epidural blood patch can often provide relief\\n\\n**Fibrin Glue Sealant:**\\n- Placement of percutaneous fibrin glue to form a clot and arrest the leakage\\n\\n**Surgical Treatments:**\\n- Neurosurgical repair to directly repair leaking meningeal diverticula\\n- Ligation of the areas of dura leak and placement of a metal clip\\n- Pledget placement over the dura leak sealed with gel foam and fibrin glue\\n- Use of a surgical lumbar drain to decrease spinal CSF volume and increase intracranial CSF pressure\\n- Primary suturing (rare)\\n\\n**Adjunct Measures:**\\n- Antibiotics to prevent meningitis (unclear benefit when due to skull fracture)\\n\\n**Recovery Support:**\\n- Symptomatic treatment like mentioned conservative treatments may continue after surgical interventions to assist in recovery.\\n\\n**Investigative Treatments:**\\n- Tetracosactide (corticotropin) to stimulate additional CSF production\\n- Epidural saline infusion to temporarily restore CSF volume\\n- Intrathecal saline infusion for urgent cases such as intractable pain or decreased consciousness\\n\\nPlease note that this list is based purely on the provided text and does not include every possible treatment option. The choice of treatment depends on various factors, including the cause, location, and severity of the CSF leak, as well as the patient's overall health status. It is essential to consult with a healthcare professional for an accurate diagnosis and an appropriate treatment plan.\", role='assistant', function_call=None, tool_calls=None)",
    "482.9:  Bacterial pneumonia": "ChatCompletionMessage(content='- Antibiotics (general, not specific to any organism)\\n- Amoxicillin\\n- Clarithromycin\\n- Azithromycin\\n- Fluoroquinolones\\n- Erythromycin\\n- Cefuroxime\\n- Flucloxacillin\\n- Doxycycline\\n- Second-generation cephalosporins (e.g., cefaclor)\\n- Ciprofloxacin\\n- Rifampicin (in combination with erythromycin for Legionella pneumophila)\\n\\nSupportive therapies mentioned:\\n- Ventilation (oxygen supplementation)\\n- Artificial ventilation and intensive care in severe cases\\n\\nPreventive measures:\\n- Pneumococcal polysaccharide vaccine (for adults)\\n- Pneumococcal conjugate vaccine (for children)\\n- Vaccination against Haemophilus influenzae type B, meningococcus, Bordetella pertussis, Bacillus anthracis, and Yersinia pestis', role='assistant', function_call=None, tool_calls=None)",
    "486:  Mycoplasma pneumonia": "ChatCompletionMessage(content='- Erythromycin\\n- Doxycycline', role='assistant', function_call=None, tool_calls=None)",
    "491.21:  Acute bronchitis": "ChatCompletionMessage(content='- Rest\\n- Paracetamol (acetaminophen) for fever and pain relief\\n- Nonsteroidal anti-inflammatory drugs (NSAIDs) for fever\\n- Avoidance of smoking and lung irritants\\n- Increase fluid intake to stay well hydrated\\n- Cough medicines (though limited support for use and not recommended for children under six years of age)\\n- Honey and pelargonium (tentative evidence supports use to help with symptoms)\\n- Inhaled bronchodilators like salbutamol for adults with wheezing due to restricted airways (weak evidence; can lead to nervousness, shakiness, or tremor)\\n- Antibiotics (generally not recommended except for pertussis or in susceptible groups such as the frail and elderly where there might be a benefit)\\n- Smoking cessation to aid healing of the bronchial tree\\n\\nPlease note that these treatments should be administered under the guidance of a healthcare professional.', role='assistant', function_call=None, tool_calls=None)",
    "491.8:  Bronchitis": "ChatCompletionMessage(content='### Treatments for Acute Bronchitis:\\n- Rest\\n- Paracetamol (acetaminophen)\\n- Nonsteroidal anti-inflammatory drugs (NSAIDs) for fever\\n- Tentative evidence for:\\n  - Salbutamol for wheezing (may cause nervousness and tremors)\\n- Honey and pelargonium (to help with symptoms)\\n- Adequate fluid intake\\n- Avoiding smoking and lung irritants\\n- Frequent hand washing\\n- Antibiotics (generally not recommended unless for pertussis infections)\\n\\n### Treatments for Chronic Bronchitis:\\n- Quitting smoking\\n- Vaccinations\\n- Pulmonary rehabilitation\\n- Inhaled bronchodilators\\n- Inhaled steroids\\n- Long-term oxygen therapy (for some individuals)\\n- Mucolytics (e.g. guaifenesin and erdosteine to decrease exacerbations)\\n- Phosphodiesterase-4 inhibitor (e.g. roflumilast for significant exacerbations)\\n\\nTreatment for Protracted Bacterial Bronchitis in Children:\\n- Antibiotics\\n\\nOther conditions mentioned (but without specific treatments listed in the text):\\n- Plastic Bronchitis\\n- Eosinophilic Bronchitis\\n- Aspergillus Bronchitis\\n\\n(Note: This list includes treatments that were mentioned in the text above. Clinical recommendations may evolve, and it is always important to consult with a healthcare provider for current treatment guidelines.)', role='assistant', function_call=None, tool_calls=None)",
    "496:  Chronic obstructive pulmonary disease": "ChatCompletionMessage(content='- Smoking cessation\\n- Vaccinations\\n- Pulmonary rehabilitation\\n- Inhaled bronchodilators\\n- Inhaled corticosteroids\\n- Long-term oxygen therapy\\n- Lung volume reduction\\n- Lung transplantation\\n- Increased use of medications during exacerbations\\n- Antibiotics\\n- Corticosteroids\\n- Hospitalization', role='assistant', function_call=None, tool_calls=None)",
    "511.9:  Pleural effusion": "ChatCompletionMessage(content='Treatments for Pleural Effusion:\\n\\n- **Therapeutic aspiration**: Sometimes removing a sample of fluid is also therapeutic.\\n  \\n- **Insertion of an intercostal drain**: May be either a pigtail catheter or a more traditional surgical drain.\\n  \\n- **Chest tube management**: Ensuring chest tubes do not become occluded to avoid residual fluid and complications.\\n  \\n- **Chemical pleurodesis**: Agents like talc, bleomycin, tetracycline, or doxycycline are used to scar pleural surfaces together.\\n  \\n- **Surgical pleurodesis**: Mechanically abrading the pleura or inserting chemicals to induce scarring, often requiring prolonged hospital stays.\\n  \\n- **Use of PleurX Pleural Catheter or Aspira Drainage Catheter**: Allows outpatient management of malignant pleural effusions with periodic fluid removal.\\n  \\n- **Antituberculosis treatment (ATT)**: For tubercular pleural effusion, typically involves an initial course of isoniazid, rifampicin, ethambutol, and pyrazinamide, followed by a continuation phase with isoniazid, rifampicin, and ethambutol.', role='assistant', function_call=None, tool_calls=None)"
}